Schedule | The Aesthetic Show 2019 | Nikolay Turovets, Ph.D.

The Aesthetic Show is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This schedule refers to the 2019 content. Please keep an eye out for when we announce our 2020 program!

View, browse and sort the sessions by pass type, track and format. With this Schedule Builder, you can create your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

In order to create your schedule, you must be registered for The Aesthetic Show 2019. If you need to register, please click here: The Aesthetic Show 2019 Registration Link

**Creating an account or schedule using this tool does not confirm your registration for The Aesthetic Show or attendance at any Pre-Show, Special Focus Course or Scientific Workshop. To book your space at any Pre-Show, Special Focus Course or Scientific Workshop, please call +1 949-830-5409.

* Program and schedule subject to change. Additional presentations and workshops are still being added so check back periodically.

Nikolay Turovets, Ph.D.CEODefenAge/MediCell Technologies

Dr. Turovets is an invention scientist behind the defensin anti-aging technology and the CEO at DefenAge Skincare. He brought into DefenAge more than 20 years of expertise in drug development and scientific and clinical operations, including cancer research, stem cell therapies and IVF. Before joining DefenAge, he led scientific operations of a multi-disciplinary team of scientists at UC Irvine to obtain US FDA clearance for a clinical trial of the first drug to cure retinitis pigmentosa using high-purity live stem cells. Dr. Turovets is a key member of the first team that intentionally derived pluripotent stem cells from unfertilized human eggs which were published in Elsevier’s Encyclopedia of Human Biology.